Register
Login:
Share:
Email Facebook Twitter




SAR Share Chat - RSS Feed

Sareum Share Chat (SAR)



Share Price: 0.22Bid: 0.21Ask: 0.23Change: 0.005 (+2.33%)Riser - Sareum
Spread: 0.02Spread as %: 9.52%Open: 0.215High: 0.225Low: 0.215Yesterday’s Close: 0.215


Share Discussion for Sareum (SAR)


Thread ViewThread View
Please Login or Register to post messages
Posts per page:


bobsbargains
Posts: 298
Off Topic
Opinion:No Opinion
Price:0.33
1000% in a week
30 Mar '15
ahh i can just remember the days when this share made the headlines hope for some positive news soon its long overdue
 
kazimira
Posts: 138
Off Topic
Opinion:No Opinion
Price:0.33
big buys
30 Mar '15
...tick up soon?
Chrisatrdg
Posts: 521
Observation
Opinion:Strong Buy
Price:0.33
Good News
29 Mar '15
hTTp://7thspace.com/headlines/505835/topotecan_synergizes_with_chek1_chk1_inhibitor_to_induce_apoptosis_in_ovarian_cancer_cells.html
Num4
Posts: 601
Observation
Opinion:Weak Buy
Price:0.33
Good News
28 Mar '15
http://7thspace.com/headlines/505835/topotecan_synergizes_with_chek1_chk1_inhibitor_to_induce_apoptosis_in_ovarian_cancer_cells.html

With positive news like the above and further proof that CHK1 is effective in many cancer's in a combination should make this early deal for big pharma a no-brainer. The question is, will they wait until the safety profile is completed - more than likely yes. So it looks like it's going to be a dull summer, and i'm not talking about the weather.
Tim could still pull something off yet though, like confirmation of funding from grant for chk1 - which would lift the share price, slightly. 2016 will be the year for Sareum IMO.
Hopkirk
Posts: 1,295
Off Topic
Opinion:No Opinion
Price:0.33
View Thread (8)
RE: checkpoint related application:
27 Mar '15
cobaltblue. If I had to come up with a list of things to worry about in relation to SAR, Paul Harper wouldn't make the top ten.

Failure of CHK1 getting to Clinical trials would top the list.

IMO and all that. GLA
colbaltblue
Posts: 774
Observation
Opinion:No Opinion
Price:0.33
View Thread (8)
RE: checkpoint related application:
26 Mar '15
Hi Fred, I just thought I was missing something and couldn't see the connection!

I hope this share comes to life. I've been here a few years and I do worry about the "dead hand" of Dr PH!
Fredd1eboy
Posts: 946
Premium Chat Member
Off Topic
Opinion:No Opinion
Price:0.33
View Thread (8)
RE: checkpoint related application:
25 Mar '15
Hi cobalt. 'not a lot' I guess.
However from one whose feeling a bit depressed with the entire aim biotechnology business, it's comforting to know someone's releasing some good news. Thanks for keeping us all on the straight and narrow. Best wishes. Freddie
colbaltblue
Posts: 774
Question
Opinion:No Opinion
Price:0.33
View Thread (8)
RE: checkpoint related application:
25 Mar '15
What's this got to do with SAR?
Fredd1eboy
Posts: 946
Premium Chat Member
Off Topic
Opinion:No Opinion
Price:0.35
View Thread (8)
RE: checkpoint related application:
24 Mar '15
Correction to last post.....
Connington (although the auto correct has provided a more appropriate description) =Continuing
Fredd1eboy
Posts: 946
Premium Chat Member
Observation
Opinion:No Opinion
Price:0.33
View Thread (8)
RE: checkpoint related application:
24 Mar '15
Connington to follow tradition, the mms APPEAR to create a nice rise in sp.
As the value of our stock is based on the sell price, it never seems to increase in line with the buy offer.
Greedy bu##ers





Sign up for Live Prices


Home  |  Contact Us  |  About Us  |  Careers  |  Advertise with Us  |  Sitemap  |  Terms & Conditions  |  Cookies  |  Privacy


Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.